Lily Chu

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Revision as of 04:18, April 13, 2017 by Kmdenmark (talk | contribs) (added cat)
Source: iacfsme.org

Lily Chu, MD, MSHS, is board certified in both internal medicine and geriatric medicine.[1] In 2006, she developed myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).[2]

Education[edit | edit source]

As per LinkedIn bio:[3]

  • Geriatric Medicine Fellowship, University of California, Los Angeles
  • MSHS, Public Health, University of California, Los Angeles
  • Internal Medicine Residency, University of Rochester
  • MD, University of Washington
  • BS, Biology, University of Washington

Boards and Committees[edit | edit source]

Publications[edit | edit source]

  • May 2016, Suicide and ME/CFS -- Lily Chu, MD, MSHS
  • 2012, "Exercise and chronic fatigue syndrome: maximize function, minimize post-exertional malaise," Letter to the Editor, European Journal of Clinical Investigation[7]

April 2013 FDA Workshop Survey[edit | edit source]

Open Letter to The Lancet[edit | edit source]

Two open letters to the editor of The Lancet urged the editor to commission a fully independent review of the PACE trial, which the journal had published in 2011. In 2016, Dr. Chu, along with 41 colleagues in the ME/CFS field, signed the second letter.

Quotes[edit | edit source]

  • 2016 - "Ultimately the best way to prevent suicide in ME/CFS will be to find effective disease-modifying treatments or cures for it."[8]

Talks and Interviews[edit | edit source]

Written questions and answers to Dr. Chu's webinar

Questions to NIH during Advocacy Call[edit | edit source]

HHS/CFSAC Testimony[edit | edit source]

Online Presence[edit | edit source]

References[edit | edit source]